Treatment Outcome Clinical Trial
— LARGEOfficial title:
Comparing Mortality, Revision Rates, and Patient-Reported Outcomes With Different Stem Lengths of the Lubinus SPII Cemented Hip Stem: A Target Trial Emulation.
Verified date | April 2024 |
Source | JointResearch |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The research questions this study aims to answer are as follows: Primary research question: "Do primary total hip arthroplasties for patients with OA, hip fracture or osteonecrosis with the 150mm Lubinus SPII hip stem have better mortality and stem revision rates than primary total hip arthroplasties with the 130mm hip stem?" Secondary aims include: - How does line-to-line cementation, compare to undersized cementation in primary total hip arthroplasty for patients with OA, hip fracture, or osteonecrosis when comparing equal size Lubinus SPII hip stems implanted with different cementation techniques? - Does the Lubinus SPII 150mm hip stem perform equal to the Lubinus SPII 130mm hip stem in primary total hip arthroplasties for patients with OA, hip fracture or osteonecrosis when comparing patient reported outcome measures? To answer these questions, this study has been allowed use of registered data from the LROI (dutch arthroplasty registry) and the SAR (swedish arthroplasty registry). After exclusion of patients who did not meet inclusion criteria between 2007-2020, approximately 110000 patients remain eligible for analysis.
Status | Enrolling by invitation |
Enrollment | 110000 |
Est. completion date | January 8, 2025 |
Est. primary completion date | July 14, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 105 Years |
Eligibility | Inclusion Criteria: - Listed in registry for primary hip arthroplasty. - Listed in registry with an indication of osteoarthritis, osteonecrosis or hip fracture. - Received the Lubinus SPII hip stem, 130mm or 150mm, for their primary hip arthro- plasty. - End point listed in registry (Alive, Deceased or revision). Exclusion Criteria: - Patients who received the Lubinus SPII 150 XL conus stem. |
Country | Name | City | State |
---|---|---|---|
Netherlands | OLVG | Amsterdam | Noord Holland |
Lead Sponsor | Collaborator |
---|---|
JointResearch | Göteborg University, Leiden University Medical Center, OLVG, Uppsala University |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality rate | Time from primary hip surgery to patient death, per hip stem length | From date of surgery to date of event (death), minimally 2 years up to 16 years (2007-2023) | |
Primary | Revision rate | Time from primary hip surgery to implant failure, per hip stem length | From date of surgery to date of event (revision), minimally 2 years up to 16 years (2007-2023) | |
Secondary | NRS pain score | pain score for rest and activity, rated 0 - 10 (10 is max pain) | before surgery, 3-6 months after surgery, 12 months after surgery | |
Secondary | Oxford hip score | Hip functionality and pain intensity score , 0 - 60, 60 is max pain/least functionality | before surgery, 3-6 months after surgery, 12 months after surgery | |
Secondary | EQ - 5D | Quality of life measurement based on 5 questions with a score of 0 - 100 (how well does patient experience health, 100 is best) | before surgery, 3-6 months after surgery, 12 months after surgery | |
Secondary | HOOS - PS | Hip functionality, disability and pain test, 5 point liker scale ( 0 - 4), higher score is more functional difficulty | before surgery, 3-6 months after surgery, 12 months after surgery | |
Secondary | Revision rate | Time from primary hip surgery to implant failure, per cementation type | From date of surgery to date of event (death), minimally 2 years up to 16 years (2007-2023) | |
Secondary | Mortality rate | Time from primary hip surgery to patient death, per cementation type | From date of surgery to date of event (revision), minimally 2 years up to 16 years (2007-2023) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02993029 -
99Tc-MDP Treatment for Knee Osteoarthritis
|
N/A | |
Enrolling by invitation |
NCT05411393 -
Synergizing Home Health Rehabilitation Therapy
|
N/A | |
Recruiting |
NCT05621356 -
Monitoring Allergen Immunotherapy in Allergic Rhinitis
|
||
Not yet recruiting |
NCT05593380 -
The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH
|
N/A | |
Recruiting |
NCT05964725 -
The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus
|
N/A | |
Not yet recruiting |
NCT05417711 -
Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus
|
N/A | |
Recruiting |
NCT04013646 -
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03477240 -
Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients
|
||
Recruiting |
NCT06035783 -
Calcium Reduction by Orbital Atherectomy in Western Europe
|
||
Recruiting |
NCT05413707 -
Weber B Ankle Fractures With Associated Posterior Malleolus Fracture
|
N/A | |
Completed |
NCT01364649 -
Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction
|
Phase 3 | |
Completed |
NCT04682951 -
Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective Study
|
||
Recruiting |
NCT05616559 -
Precision Medicine in the Depression Treatment
|
||
Recruiting |
NCT06441110 -
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
|
Phase 3 | |
Recruiting |
NCT03223142 -
Standardization of Multi-modal Tumor Ablation Therapy System
|
N/A | |
Completed |
NCT05594160 -
Agentic Self-view as Common Factor in Psychotherapy - Self-efficacy in the Treatment of Inpatients Over the Course of Time
|
||
Recruiting |
NCT05851989 -
Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
|
||
Not yet recruiting |
NCT05885919 -
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
|
Phase 3 | |
Active, not recruiting |
NCT01235104 -
Impact of Total Nephrectomy on Patients With Kidney Stone
|
N/A | |
Completed |
NCT01183936 -
Trial of Surgical Excision Margins in Thick Primary Melanoma
|
N/A |